BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.71B |
| 2 |
Alibaba
BABA
|
+$2.19B |
| 3 |
Truist Financial
TFC
|
+$2.16B |
| 4 |
iShares MBS ETF
MBB
|
+$841M |
| 5 |
ServiceNow
NOW
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
| 5 |
Apple
AAPL
|
+$623M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 13.59% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
GSI Technology
GSIT
$258M
| $5.79M | ﹤0.01% |
816,913
-20,018
| -2% | -$151K |
|
3452
Gencor Industries
GENC
$212M
| $5.78M | ﹤0.01% |
495,476
+1,776
| +0.4% | +$21.4K |
|
3453
Silvercrest Asset Management
SAMG
$79.9M
| $5.77M | ﹤0.01% |
458,923
-8,555
| -2% | -$108K |
|
3454
Unilever
UL
$136B
| $5.73M | ﹤0.01% |
89,116
+28,922
| +48% | +$1.92M |
|
3455
Banco de Chile
BCH
$20.9B
| $5.67M | ﹤0.01% |
270,078
+144,729
| +115% | +$3.52M |
|
3456
AstroNova
ALOT
$227M
| $5.66M | ﹤0.01% |
412,782
-2,394
| -0.6% | -$36.5K |
|
|
CVIA
3457
DELISTED
Covia Holdings Corporation Common Stock
CVIA
| $5.61M | ﹤0.01% |
2,748,565
-116,548
| -4% | -$188K |
|
3458
Enel Chile
ENIC
$6.28B
| $5.59M | ﹤0.01% |
1,177,166
-72,604
| -6% | -$313K |
|
3459
Relmada Therapeutics
RLMD
$527M
| $5.58M | ﹤0.01% |
+143,113
| New | +$4.35M |
|
|
PVBC
3460
DELISTED
Provident Bancorp
PVBC
| $5.57M | ﹤0.01% |
447,226
+4,500
| +1% | +$53.1K |
|
3461
Marker Therapeutics
MRKR
$18.7M
| $5.55M | ﹤0.01% |
192,745
+9,210
| +5% | +$335K |
|
|
XIFR
3462
XPLR Infrastructure LP
XIFR
$1.08B
| $5.48M | ﹤0.01% |
104,081
+6,288
| +6% | +$327K |
|
3463
Manulife Financial
MFC
$73.5B
| $5.45M | ﹤0.01% |
268,698
+266,345
| +11,319% | +$5.09M |
|
3464
Escalade
ESCA
$311M
| $5.43M | ﹤0.01% |
552,066
+5,007
| +0.9% | +$54.3K |
|
|
HOLI
3465
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $5.39M | ﹤0.01% |
328,304
+56,669
| +21% | +$860K |
|
3466
Legacy Housing
LEGH
$694M
| $5.38M | ﹤0.01% |
323,583
+36,345
| +13% | +$570K |
|
3467
ASE Group
ASX
$82.2B
| $5.34M | ﹤0.01% |
960,123
| – | – |
|
|
CFB
3468
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $5.32M | ﹤0.01% |
368,599
+2,483
| +0.7% | +$33.5K |
|
3469
AC Immune
ACIU
$240M
| $5.31M | ﹤0.01% |
623,082
-39,093
| -6% | -$261K |
|
|
PYX
3470
DELISTED
Pyxus International, Inc.
PYX
| $5.3M | ﹤0.01% |
592,786
-1,232
| -0.2% | -$11.9K |
|
3471
KALA BIO
KALA
$14.5M
| $5.25M | ﹤0.01% |
570
-134
| -19% | -$1.29M |
|
|
ORTX
3472
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $5.2M | ﹤0.01% |
+37,794
| New | +$4.6M |
|
3473
Atlanticus Holdings
ATLC
$1.52B
| $5.18M | ﹤0.01% |
575,157
+3,432
| +0.6% | +$27.1K |
|
|
STEX
3474
Streamex Corp
STEX
$83M
| $5.17M | ﹤0.01% |
87,300
+722
| +0.8% | +$48.8K |
|
|
KDNY
3475
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $5.15M | ﹤0.01% |
872,991
-186,536
| -18% | -$1.01M |
|
Similar funds
BlackRock's Q4 2019 Portfolio in Review
As of Q4 2019, BlackRock held 5,193 positions worth $2.61T, up 9.5% from $2.38T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q4 2019 filing shows 167 new, 2,887 increased, 1,450 reduced and 161 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M. The largest sale was Celgene Corp, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M.
- BlackRock added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.71B increase.
- BlackRock's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- BlackRock fully exited Celgene Corp in Q4 2019, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 15% of its $2.61T portfolio in Q4 2019.
- BlackRock opened 167 new positions and closed 161 in Q4 2019.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $2.61T.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.